CLINICAL_TRIALS
trial_result
· 2009-06-23
Clinical Trial Update: Effects of Tadalafil Once a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia [Phase 2]
Summary
Results from a Phase 2 trial evaluating once-daily tadalafil for 12 weeks in men with signs and symptoms of benign prostatic hyperplasia, assessing efficacy and…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Benign Prostatic Hyperplasia | Phase 2 | Status: COMPLETED | Results posted: 2009-06-23